Simpirica Spine
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Simpirica Spine - overview
Established
2006
Location
San Carlos, CA, US
Primary Industry
Healthcare IT
About
Simpirica Spine is a medical device company specialized in innovative spinal implants for spinal conditions, aiming to enhance surgical outcomes with its unique technologies. Founded in 2006 and headquartered in San Carlos, US, Simpirica Spine focuses on developing spinal implants. The company has completed three funding deals, with the latest being a VENTURE DEBT round in January 2014, raising USD 5. 00 mn, bringing the total amount raised to USD 7.
45 mn. Simpirica Spine specializes in innovative spinal implants designed to address conditions such as lumbar spinal stenosis and degenerative spondylolisthesis. Their core offering, the LimiFlex Dynamic Sagittal Tether, serves as a minimally invasive alternative to traditional spinal fusion procedures, enhancing lumbar spine stability and motion after surgical decompression. It specifically targets patients suffering from grade 1 lumbar degenerative spondylolisthesis with associated spinal stenosis, marketed primarily to healthcare professionals in the US and select international markets.
Simpirica Spine generates revenue through direct sales of the LimiFlex Dynamic Sagittal Tether to healthcare providers, surgical centers, and hospitals. Their business-to-business model relies on contracts with medical institutions, facilitating the distribution of their innovative spinal products integrated into surgical practices. Simpirica Spine plans to leverage its recent VENTURE DEBT funding from January 2014 to enhance product development and expand its market presence. The company aims to introduce new spinal implant technologies within the next 18 months, targeting both the US and international markets for expansion, increasing accessibility to its innovative solutions in spinal surgery.
Current Investors
US Venture Partners, Norwest Venture Partners, De Novo Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT
Website
www.simpirica.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Simpirica Spine - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.